These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 33962533)

  • 1. Efficacy of infliximab in treatment-naïve patients with stricturing small bowel Crohn's disease.
    Chen BX; Han ZM; Zhou Q; Liu HB; Xu PC; Zhi FC
    Scand J Gastroenterol; 2021 Jul; 56(7):812-819. PubMed ID: 33962533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medical Therapies for Stricturing Crohn's Disease: Efficacy and Cross-Sectional Imaging Predictors of Therapeutic Failure.
    Campos C; Perrey A; Lambert C; Pereira B; Goutte M; Dubois A; Goutorbe F; Dapoigny M; Bommelaer G; Hordonneau C; Buisson A
    Dig Dis Sci; 2017 Jun; 62(6):1628-1636. PubMed ID: 28401425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early treatment with anti-tumor necrosis factor agents improves long-term effectiveness in symptomatic stricturing Crohn's disease.
    Rodríguez-Lago I; Hoyo JD; Pérez-Girbés A; Garrido-Marín A; Casanova MJ; Chaparro M; Fernández-Clotet A; Castro-Poceiro J; García MJ; Sánchez S; Ferreiro-Iglesias R; Bastón I; Piqueras M; Careda LEIB; Mena R; Suárez C; Cordón JP; López-García A; Márquez L; Arroyo M; Alfambra E; Sierra M; Cano N; Delgado-Guillena P; Morales-Alvarado V; Aparicio JC; Guerra I; Aulló C; Merino O; Arranz L; Hidalgo MA; Llaó J; Plaza R; Molina G; Torres P; Pérez-Galindo P; Romero MG; Herrera-deGuise C; Armesto E; Mesonero F; Frago-Larramona S; Benítez JM; Calvo M; Martín MDCL; Elorza A; Larena A; Peña E; Rodríguez-Grau MDC; Miguel-Criado J; Botella B; Olmos JA; López L; Aguirre U; Gisbert JP;
    United European Gastroenterol J; 2020 Nov; 8(9):1056-1066. PubMed ID: 32723069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serial Changes in Intestinal Stenotic Stiffness in Patients with Crohn's Disease Treated with Biologics: A Pilot Study Using Ultrasound Shear Wave Elastography.
    Matsumoto H; Hata J; Yo S; Sasahira M; Misawa H; Oosawa M; Handa O; Umegami E; Shiotani A
    Turk J Gastroenterol; 2023 Oct; 34(10):1006-1013. PubMed ID: 37603302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of infliximab-induced deep remission in treatment-naïve patients with isolated small bowel Crohn's disease.
    Han ZM; Chen BX; Zhou Q; Liu HB; Xu PC; Zhi FC
    Scand J Gastroenterol; 2021 Dec; 56(12):1422-1426. PubMed ID: 34461786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Laparoscopic ileocaecal resection versus infliximab for terminal ileitis in Crohn's disease: retrospective long-term follow-up of the LIR!C trial.
    Stevens TW; Haasnoot ML; D'Haens GR; Buskens CJ; de Groof EJ; Eshuis EJ; Gardenbroek TJ; Mol B; Stokkers PCF; Bemelman WA; Ponsioen CY;
    Lancet Gastroenterol Hepatol; 2020 Oct; 5(10):900-907. PubMed ID: 32619413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of tumour necrosis factor antagonists in stricturing Crohn's disease: A tertiary center real-life experience.
    Allocca M; Bonifacio C; Fiorino G; Spinelli A; Furfaro F; Balzarini L; Bonovas S; Danese S
    Dig Liver Dis; 2017 Aug; 49(8):872-877. PubMed ID: 28416240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term efficacy of infliximab maintenance therapy for perianal Crohn's disease.
    Uchino M; Ikeuchi H; Bando T; Matsuoka H; Takesue Y; Takahashi Y; Matsumoto T; Tomita N
    World J Gastroenterol; 2011 Mar; 17(9):1174-9. PubMed ID: 21448422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evolution After Anti-TNF Discontinuation in Patients With Inflammatory Bowel Disease: A Multicenter Long-Term Follow-Up Study.
    Casanova MJ; Chaparro M; García-Sánchez V; Nantes O; Leo E; Rojas-Feria M; Jauregui-Amezaga A; García-López S; Huguet JM; Arguelles-Arias F; Aicart M; Marín-Jiménez I; Gómez-García M; Muñoz F; Esteve M; Bujanda L; Cortés X; Tosca J; Pineda JR; Mañosa M; Llaó J; Guardiola J; Pérez-Martínez I; Muñoz C; González-Lama Y; Hinojosa J; Vázquez JM; Martinez-Montiel MP; Rodríguez GE; Pajares R; García-Sepulcre MF; Hernández-Martínez A; Pérez-Calle JL; Beltrán B; Busquets D; Ramos L; Bermejo F; Barrio J; Barreiro-de Acosta M; Roncedo O; Calvet X; Hervías D; Gomollón F; Domínguez-Antonaya M; Alcaín G; Sicilia B; Dueñas C; Gutiérrez A; Lorente-Poyatos R; Domínguez M; Khorrami S; Muñoz C; Taxonera C; Rodríguez-Pérez A; Ponferrada A; Van Domselaar M; Arias-Rivera ML; Merino O; Castro E; Marrero JM; Martín-Arranz M; Botella B; Fernández-Salazar L; Monfort D; Opio V; García-Herola A; Menacho M; Ramírez-de la Piscina P; Ceballos D; Almela P; Navarro-Llavat M; Robles-Alonso V; Vega-López AB; Moraleja I; Novella MT; Castaño-Milla C; Sánchez-Torres A; Benítez JM; Rodríguez C; Castro L; Garrido E; Domènech E; García-Planella E; Gisbert JP
    Am J Gastroenterol; 2017 Jan; 112(1):120-131. PubMed ID: 27958281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Endoscopic Dilation vs Surgery for Anastomotic Stricture in Patients With Crohn's Disease Following Ileocolonic Resection.
    Lian L; Stocchi L; Remzi FH; Shen B
    Clin Gastroenterol Hepatol; 2017 Aug; 15(8):1226-1231. PubMed ID: 27816758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Visceral adiposity and inflammatory bowel disease.
    Rowan CR; McManus J; Boland K; O'Toole A
    Int J Colorectal Dis; 2021 Nov; 36(11):2305-2319. PubMed ID: 34104989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Real world analysis on the efficacy and safety of anti-tumor necrosis factor therapy in patients with stricturing Crohn's disease.
    Vuyyuru SK; Kante B; Kumar P; Sahu P; Kedia S; Ranjan MK; Sharma R; Panwar R; Makharia G; Ahuja V
    Sci Rep; 2021 Jun; 11(1):11704. PubMed ID: 34083575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A nationwide, multi-center, retrospective study of symptomatic small bowel stricture in patients with Crohn's disease.
    Bamba S; Sakemi R; Fujii T; Takeda T; Fujioka S; Takenaka K; Kitamoto H; Umezawa S; Sakuraba H; Inokuchi T; Fukata N; Mizuno S; Yamashita M; Shinzaki S; Tanaka H; Takedatsu H; Ozaki R; Moriya K; Ishii M; Kinjo T; Ozeki K; Ooi M; Hayashi R; Kakimoto K; Shimodate Y; Kitamura K; Yamada A; Sonoda A; Nishida Y; Yoshioka K; Ashizuka S; Takahashi F; Shimokawa T; Kobayashi T; Andoh A; Hibi T
    J Gastroenterol; 2020 Jun; 55(6):615-626. PubMed ID: 31989252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term outcome of perianal fistulizing Crohn's disease treated with infliximab.
    Bouguen G; Siproudhis L; Gizard E; Wallenhorst T; Billioud V; Bretagne JF; Bigard MA; Peyrin-Biroulet L
    Clin Gastroenterol Hepatol; 2013 Aug; 11(8):975-81.e1-4. PubMed ID: 23376316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term outcome of non-fistulizing (ulcers, stricture) perianal Crohn's disease in patients treated with infliximab.
    Bouguen G; Trouilloud I; Siproudhis L; Oussalah A; Bigard MA; Bretagne JF; Peyrin-Biroulet L
    Aliment Pharmacol Ther; 2009 Oct; 30(7):749-56. PubMed ID: 19583709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of infliximab with adalimumab in 827 biologic-naïve patients with Crohn's disease: a population-based Danish cohort study.
    Singh S; Andersen NN; Andersson M; Loftus EV; Jess T
    Aliment Pharmacol Ther; 2018 Mar; 47(5):596-604. PubMed ID: 29239001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Laparoscopic ileocaecal resection versus infliximab for terminal ileitis in Crohn's disease: a randomised controlled, open-label, multicentre trial.
    Ponsioen CY; de Groof EJ; Eshuis EJ; Gardenbroek TJ; Bossuyt PMM; Hart A; Warusavitarne J; Buskens CJ; van Bodegraven AA; Brink MA; Consten ECJ; van Wagensveld BA; Rijk MCM; Crolla RMPH; Noomen CG; Houdijk APJ; Mallant RC; Boom M; Marsman WA; Stockmann HB; Mol B; de Groof AJ; Stokkers PC; D'Haens GR; Bemelman WA;
    Lancet Gastroenterol Hepatol; 2017 Nov; 2(11):785-792. PubMed ID: 28838644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Propensity Score-matched Comparison of Infliximab and Adalimumab in Tumour Necrosis Factor-α Inhibitor-naïve and Non-naïve Patients With Crohn's Disease: Real-Life Data From the Sicilian Network for Inflammatory Bowel Disease.
    Macaluso FS; Fries W; Privitera AC; Cappello M; Siringo S; Inserra G; Magnano A; Di Mitri R; Mocciaro F; Belluardo N; Scarpulla G; Magrì G; Trovatello A; Carroccio A; Genova S; Bertolami C; Vassallo R; Romano C; Citrano M; Accomando S; Ventimiglia M; Renna S; Orlando R; Rizzuto G; Porcari S; Ferracane C; Cottone M; Orlando A;
    J Crohns Colitis; 2019 Feb; 13(2):209-217. PubMed ID: 30295785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of double-balloon endoscopy and an endoscopic scoring system to assess endoscopic remission in isolated small bowel Crohn's disease after treatment with infliximab.
    Han W; Hu J; Wu J; Zhang P; Liu Q; Hu N; Mei Q
    Therap Adv Gastroenterol; 2024; 17():17562848231224842. PubMed ID: 38250016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term outcome of patients with Crohn's disease who discontinued infliximab therapy upon clinical remission.
    Papamichael K; Vande Casteele N; Gils A; Tops S; Hauenstein S; Singh S; Princen F; Van Assche G; Rutgeerts P; Vermeire S; Ferrante M
    Clin Gastroenterol Hepatol; 2015 Jun; 13(6):1103-10. PubMed ID: 25478919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.